Market Cap 2.55B
Revenue (ttm) 5.78B
Net Income (ttm) 86.00M
EPS (ttm) N/A
PE Ratio 21.26
Forward PE 11.99
Profit Margin 1.49%
Debt to Equity Ratio 13.83
Volume 2,374,527
Avg Vol 3,116,200
Day's Range N/A - N/A
Shares Out 149.89M
Stochastic %K 16%
Beta 1.63
Analysts Sell
Price Target $16.33

Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offe...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 302 773 1000
Address:
1007 Market Street, P.O. Box 2047, Wilmington, United States
ALRAE
ALRAE Feb. 23 at 7:05 PM
$CC 50+
0 · Reply
koditrump
koditrump Feb. 23 at 6:36 PM
0 · Reply
erevnon
erevnon Feb. 23 at 6:12 PM
Morgan Stanley maintains Chemours $CC at Equal-Weight and raises the price target from $15 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
ZacksResearch
ZacksResearch Feb. 23 at 6:03 PM
$CC beats on earnings — but the headline loss just widened year over year. So what’s really going on? Q4 sales dipped 2% and the company posted a wider y/y loss, yet the bottom line still topped estimates as Thermal & Specialized Solutions surged on strong refrigerant pricing. That segment strength is doing some heavy lifting. 🔥 Is this early stabilization or just a temporary boost from pricing? Get the full picture 👉 https://www.zacks.com/stock/news/2873782/chemours-q4-earnings-surpass-estimates-revenues-in-line?cid=sm-stocktwits-2-2873782-teaser-34756&ADID=SYND_STOCKTWITS_TWEET_2_2873782_TEASER_34756
0 · Reply
ZacksResearch
ZacksResearch Feb. 23 at 5:03 PM
$CC posts a bigger Q4 loss, but beats earnings estimates 📉 🔹 Net loss widened to 31 cents per share, but earnings per share excluding one-time items beat the Zacks Consensus Estimate. 🔹 Sales dipped 2.2%, in line with expectations. The Titanium Technologies division saw an 11% revenue decline. 🔹 Thermal & Specialized Solutions shone with a 14% revenue jump, driven by strong demand for Opteon refrigerants. See why CC carries a Zacks Rank #4 (Sell) and what it means for investors 👉 https://www.zacks.com/stock/news/2873782/chemours-q4-earnings-surpass-estimates-revenues-in-line?cid=sm-stocktwits-2-2873782-body-34735&ADID=SYND_STOCKTWITS_TWEET_2_2873782_BODY_34735
0 · Reply
MelanieStiegman869
MelanieStiegman869 Feb. 21 at 7:28 AM
$CC Chemours manufactures specialty chemicals. Earnings depend on industrial demand. Environmental liabilities remain a risk.
0 · Reply
ALRAE
ALRAE Feb. 20 at 9:13 PM
$CC I feel sorry for anyone who shorted this today. $50+
0 · Reply
lozzamozza
lozzamozza Feb. 20 at 6:36 PM
0 · Reply
JHR
JHR Feb. 20 at 4:16 PM
$CC I do like this. Maybe I nibble a bit here and see what happens
0 · Reply
ALRAE
ALRAE Feb. 20 at 4:12 PM
$CC 50+ .....
1 · Reply
Latest News on CC
The Chemours Company (CC) Q4 2025 Earnings Call Transcript

Feb 20, 2026, 12:15 PM EST - 3 days ago

The Chemours Company (CC) Q4 2025 Earnings Call Transcript


Chemours Announces First Quarter Dividend

Feb 17, 2026, 4:30 PM EST - 5 days ago

Chemours Announces First Quarter Dividend


Chemours: Upside More Confirmed In 2026E

Jan 29, 2026, 2:22 AM EST - 25 days ago

Chemours: Upside More Confirmed In 2026E


Chemours: Solid Momentum Despite One-Time Costs In Q3

Nov 11, 2025, 11:14 AM EST - 3 months ago

Chemours: Solid Momentum Despite One-Time Costs In Q3


The Chemours Company (CC) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 11:46 AM EST - 3 months ago

The Chemours Company (CC) Q3 2025 Earnings Call Transcript


Chemours Stock Drops. Here's Why.

Nov 7, 2025, 11:33 AM EST - 3 months ago

Chemours Stock Drops. Here's Why.


The Chemours Company Reports Third Quarter 2025 Results

Nov 6, 2025, 4:30 PM EST - 3 months ago

The Chemours Company Reports Third Quarter 2025 Results


Chemours Announces Fourth Quarter Dividend

Oct 29, 2025, 5:00 PM EDT - 4 months ago

Chemours Announces Fourth Quarter Dividend


Chemours: Getting In Before The Upside And Before Q3

Oct 28, 2025, 5:54 PM EDT - 4 months ago

Chemours: Getting In Before The Upside And Before Q3


The Chemours Company (CC) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 10:19 AM EDT - 7 months ago

The Chemours Company (CC) Q2 2025 Earnings Call Transcript


The Chemours Company Reports Second Quarter 2025 Results

Aug 5, 2025, 4:56 PM EDT - 7 months ago

The Chemours Company Reports Second Quarter 2025 Results


Chemours Guides for 2Q Sales at High End of Prior Forecast

Jun 18, 2025, 7:10 AM EDT - 8 months ago

Chemours Guides for 2Q Sales at High End of Prior Forecast


Chemours Appoints Matthew Conti as Chief Human Resources Officer

Jun 12, 2025, 4:30 PM EDT - 9 months ago

Chemours Appoints Matthew Conti as Chief Human Resources Officer


The Chemours Company (CC) Q1 2025 Earnings Call Transcript

May 7, 2025, 2:05 PM EDT - 10 months ago

The Chemours Company (CC) Q1 2025 Earnings Call Transcript


Chemours: Dividend Cut May Signal A Bottom Is Near

May 6, 2025, 11:41 PM EDT - 10 months ago

Chemours: Dividend Cut May Signal A Bottom Is Near


The Chemours Company Reports First Quarter 2025 Results

May 6, 2025, 4:30 PM EDT - 10 months ago

The Chemours Company Reports First Quarter 2025 Results


The Long-Term Upside For Chemours Company After Q4 2024

Feb 19, 2025, 7:01 AM EST - 1 year ago

The Long-Term Upside For Chemours Company After Q4 2024


The Chemours Company (CC) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 11:06 AM EST - 1 year ago

The Chemours Company (CC) Q4 2024 Earnings Call Transcript


Chemours Appoints Leslie M. Turner to its Board of Directors

Feb 11, 2025, 4:30 PM EST - 1 year ago

Chemours Appoints Leslie M. Turner to its Board of Directors


ALRAE
ALRAE Feb. 23 at 7:05 PM
$CC 50+
0 · Reply
koditrump
koditrump Feb. 23 at 6:36 PM
0 · Reply
erevnon
erevnon Feb. 23 at 6:12 PM
Morgan Stanley maintains Chemours $CC at Equal-Weight and raises the price target from $15 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
ZacksResearch
ZacksResearch Feb. 23 at 6:03 PM
$CC beats on earnings — but the headline loss just widened year over year. So what’s really going on? Q4 sales dipped 2% and the company posted a wider y/y loss, yet the bottom line still topped estimates as Thermal & Specialized Solutions surged on strong refrigerant pricing. That segment strength is doing some heavy lifting. 🔥 Is this early stabilization or just a temporary boost from pricing? Get the full picture 👉 https://www.zacks.com/stock/news/2873782/chemours-q4-earnings-surpass-estimates-revenues-in-line?cid=sm-stocktwits-2-2873782-teaser-34756&ADID=SYND_STOCKTWITS_TWEET_2_2873782_TEASER_34756
0 · Reply
ZacksResearch
ZacksResearch Feb. 23 at 5:03 PM
$CC posts a bigger Q4 loss, but beats earnings estimates 📉 🔹 Net loss widened to 31 cents per share, but earnings per share excluding one-time items beat the Zacks Consensus Estimate. 🔹 Sales dipped 2.2%, in line with expectations. The Titanium Technologies division saw an 11% revenue decline. 🔹 Thermal & Specialized Solutions shone with a 14% revenue jump, driven by strong demand for Opteon refrigerants. See why CC carries a Zacks Rank #4 (Sell) and what it means for investors 👉 https://www.zacks.com/stock/news/2873782/chemours-q4-earnings-surpass-estimates-revenues-in-line?cid=sm-stocktwits-2-2873782-body-34735&ADID=SYND_STOCKTWITS_TWEET_2_2873782_BODY_34735
0 · Reply
MelanieStiegman869
MelanieStiegman869 Feb. 21 at 7:28 AM
$CC Chemours manufactures specialty chemicals. Earnings depend on industrial demand. Environmental liabilities remain a risk.
0 · Reply
ALRAE
ALRAE Feb. 20 at 9:13 PM
$CC I feel sorry for anyone who shorted this today. $50+
0 · Reply
lozzamozza
lozzamozza Feb. 20 at 6:36 PM
0 · Reply
JHR
JHR Feb. 20 at 4:16 PM
$CC I do like this. Maybe I nibble a bit here and see what happens
0 · Reply
ALRAE
ALRAE Feb. 20 at 4:12 PM
$CC 50+ .....
1 · Reply
koditrump
koditrump Feb. 20 at 3:55 PM
0 · Reply
lozzamozza
lozzamozza Feb. 20 at 2:59 PM
0 · Reply
Recon2023
Recon2023 Feb. 20 at 3:40 AM
$CC 5.92 dividend accuarate
0 · Reply
Okadarlan
Okadarlan Feb. 19 at 11:46 PM
$CC holding , avarage is 13 .
0 · Reply
ti59
ti59 Feb. 19 at 9:52 PM
$CC Who didn’t see this coming. 🤔 I warned yesterday this would get smoked.
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 19 at 9:50 PM
$CC Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.31 down -287.50% YoY • Reported revenue of $1.33B down -2.13% YoY • Chemours expects 2026 Net Sales growth of 3% to 5% and Adjusted EBITDA between $800M and $900M, driven by increased TSS and APM demand. Chemours also anticipates Free Cash Flow Conversion above 25% for the full year.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 19 at 9:50 PM
$CC Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.31 down -287.50% YoY • Reported revenue of $1.33B down -2.13% YoY • Chemours expects full year 2026 Net Sales growth of 3% to 5% and Adjusted EBITDA between $800 million and $900 million. Chemours also anticipates Free Cash Flow Conversion above 25% for the year.
0 · Reply
_TP888
_TP888 Feb. 19 at 7:16 PM
$CC | $21.00 | Call | Premium: $200K Ask-heavy - aggressive call buyers.
0 · Reply
_TP888
_TP888 Feb. 19 at 4:35 PM
$CC | $22.00 | Call | Premium: $148K Ask-heavy - aggressive call buyers.
0 · Reply
JasonCO
JasonCO Feb. 19 at 2:32 PM
$CC nice dip at open
0 · Reply
Estimize
Estimize Feb. 19 at 11:06 AM
Wall St is expecting 0.07 EPS for $CC Q4 [Reporting Today 02/19 AMC] http://www.estimize.com/intro/cc?chart=historical&metric_name=eps&utm_
0 · Reply
ti59
ti59 Feb. 18 at 3:12 PM
$CC Out in pre market. This is going to get smoked tomorrow after earnings.
0 · Reply